v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Net sales $ 1,230,936 $ 1,594,856 $ 3,331,369 $ 3,536,594
Cost of sales 517,876 984,111 1,527,174 2,081,596
Gross profit 713,060 610,745 1,804,195 1,454,998
Operating expenses:        
Selling, general and administrative 65,326 47,324 182,604 153,078
Research and development 67,223 60,592 210,410 167,468
Production start-up 34,403 36,734 69,384 85,506
Total operating expenses 166,952 144,650 462,398 406,052
Operating income 546,108 466,095 1,341,797 1,048,946
Foreign currency gain (loss), net 90 (8,903) (22,961) (30,224)
Interest income 24,151 23,308 82,933 54,273
Interest expense, net (2,390) (14,121) (15,568) (32,830)
Other expense, net (1,930) (6,034) (6,461) (10,594)
Income before taxes 566,029 460,345 1,379,740 1,029,571
Income tax benefit (expense) 5,034 (4,402) (39,489) (22,225)
Net income $ 571,063 $ 455,943 $ 1,340,251 $ 1,007,346
Net income per share:        
Basic $ 5.31 $ 4.25 $ 12.48 $ 9.40
Diluted $ 5.30 $ 4.24 $ 12.45 $ 9.37
Weighted-average number of shares used in per share calculations:        
Basic 107,472 107,264 107,430 107,211
Diluted 107,702 107,538 107,666 107,492